LASP1 and prostate carcinoma: In this respect, an increased nuclear translocation of LASP1 into the nucleus inversely correlated with patient survival (i.e., poor prognosis) in breast cancer (27), prostate cancer (55), medulloblastoma (59), and hepatocellular carcinoma (18, 48).